Fulminant myocarditis after the second dose of COVID‐19 mRNA vaccination

Myocarditis is an adverse event associated with coronavirus disease 2019 (COVID‐19) mRNA vaccination. A 50‐year‐old man presented with dyspnea and resting chest pain after receiving the second dose of the COVID‐19 mRNA vaccine and developed cardiogenic shock. Fulminant myocarditis was diagnosed by e...

Descripción completa

Detalles Bibliográficos
Autores principales: Oka, Akihiro, Sudo, Yuya, Miyoshi, Toru, Ozaki, Masatomo, Kimura, Yuta, Takagi, Wataru, Ugawa, Satoko, Okada, Tomoaki, Nosaka, Kazumasa, Doi, Masayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819635/
https://www.ncbi.nlm.nih.gov/pubmed/35154722
http://dx.doi.org/10.1002/ccr3.5378
Descripción
Sumario:Myocarditis is an adverse event associated with coronavirus disease 2019 (COVID‐19) mRNA vaccination. A 50‐year‐old man presented with dyspnea and resting chest pain after receiving the second dose of the COVID‐19 mRNA vaccine and developed cardiogenic shock. Fulminant myocarditis was diagnosed by endomyocardial biopsy and treated with intravenous corticosteroids.

Ejemplares similares